Healthcare is such a critically important issue and I have heard from many of you who have shared your thoughts and concerns regarding the Affordable Care Act (ACA). While I agree the ACA needs improvement, depriving 24 million Americans of affordable healthcare is not the solution. As you may know, the ACA contains provisions intended to allow more Americans to access quality healthcare by increasing the primary care and public health workforce, promoting preventive services, and strengthening quality controls, among other things.
The Republican alternative has many deficiencies including eliminating coverage for preexisting conditions and undoing Medicaid expansion; which are just a sampling of what is vital to so many individuals in our district. Additionally, their cruel and reckless plan would rob too many Americans of the healthcare coverage they now have.
It is my firm belief that access to healthcare is not a privilege, but a right. Therefore, I am in strong opposition to attempts to deny Americans the healthcare coverage they deserve and will continue to fight any efforts to undermine their healthcare.
More on Health Care
CHICAGO — Yesterday, U.S. Representative Bobby L. Rush (D-Ill.) delivered the following opening remarks at the Energy and Commerce Committee's Subcommittee on Health field hearing on "A Public Health Crisis: The Gun Violence Epidemic."
Rep. Rush's Opening Statement as Prepared for Delivery:
WASHINGTON — Today, U.S. Representative Bobby L. Rush (D-Ill.) voted in support of the Continuing Appropriations Act of 2020 and the Health Extenders Act of 2019, which will, among other things, extend the Community Health Centers Fund and the National Flood Insurance Program through Nov. 21, 2019. The bill passed the House of Representatives by a vote of 301-to-123.
WASHINGTON — Today, U.S. Representative Bobby L. Rush (D-Ill.) reintroduced an important piece of legislation that would require drug companies to properly label products that present an increased risk of suicide or depression as a side effect.
The Depression Effect Labeling Awareness Act of 2019 (H.R. 4404) was originally introduced last year by Rep. Rush and would amend the Federal Food, Drug, and Cosmetic Act to require that the label of drugs with an increased risk of suicide or depression present such increased risk prominently.
WASHINGTON — U.S. Representatives Bobby L. Rush (D-Ill.) and Katie Porter (D-Cal.) sent a letter to Health and Human Services (HHS) Secretary Alex Azar and Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma, calling on the Administration to consider the impact of both current and future policies on vulnerable populations receiving dialysis treatment. Representatives Rush and Porter are particularly concerned with the rapid explosion of dialysis centers in poorer, largely minority, communities.